The invention belongs to the field of analysis and detection, and provides a
CRISPR (clustered regularly interspaced short palindromic repeats)-based
DNA /
RNA (deoxyribonucleic acid / ribonucleic acid)
synchronous detection method and a
CRISPR-based
DNA /
RNA synchronous detection platform and application of the
CRISPR-based
DNA /
RNA synchronous detection platform in
respiratory tract pathogen multiplex detection.The CRISPR-based DNA / RNA synchronous detection method comprises the steps that corresponding crRNA is designed according to
nucleic acid to be detected, the
nucleic acid to be detected is mixed and incubated with a Cas12a-crRNA compound or a Cas13a-crRNA compound and then mixed and incubated with MB (at) LP-
linker-FB according to the claim 6, and after incubation is finished, DNA / RNA synchronous detection is carried out. And performing
magnetic separation, collecting supernate, adding Triton X-100 for
cracking MB-coated LP, and detecting
peak current generated by MB by adopting DPV, thereby obtaining the MB-coated LP. According to the invention, a general
nucleic acid detection strategy with a synergistic effect of a CRISPR / Cas
system and a
liposome nano container is constructed, and then a parallel loading
system of Cas12a and Cas13a is established based on a multi-channel centrifugal microfluidic detection platform, so that multi-linked detection of pathogens with
genetic materials, namely DNA and RNA, in a
single sample is realized. According to the designed MB-coated LP-
linker-FB
composite signal carrier, on one hand, the MB packaging efficiency and the release
control force are improved, and on the other hand, a highly
specific detection mechanism is established through
enzyme digestion response.